Want to stay up to date on the science and politics driving biotechnology today? Sign up to receive our biotech newsletter in your inbox. Good morning....
A leading provider of exchange-traded funds is betting on the long-term popularity of GLP-1 weight loss drugs. Roundhill Investments’ GLP-1 & Weight Loss ETF (OZEM), which...
Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-related liver disease, and as part of that will investigate whether the treatments will...
Want to stay up to date on the science and politics driving biotechnology today? Sign up to receive our biotech newsletter in your inbox. Good morning!...
Want to stay up to date on the science and politics driving biotechnology today? Sign up to receive our biotech newsletter in your inbox. Good morning,...
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.